In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 63, Issue 2, 2006, Pages 215-220

  Kang, Mi Lan ^a   Kang, Sang Gyun ^a   Jiang, Hu Lin ^a   Shin, Seung Won ^a   Lee, Deog Yong ^a   Ahn, Jeong Min ^a   Rayamahji, Nabin ^a   Park, In Kyu ^a   Shin, Sung Jae ^a   Cho, Chong Su ^a   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

Author keywords

Bordetella bronchiseptica; Chitosan microspheres; DNT; Mucosal immunity; Nasal administration

Indexed keywords

ANTIBODY; BACTERIAL TOXIN; CHITOSAN; DERMONECROTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICROSPHERE; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATROPHIC RHINITIS; BLOOD ANALYSIS; BORDETELLA BRONCHISEPTICA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GELATION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; SALIVA ANALYSIS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA BRONCHISEPTICA; CELL LINE; CHITOSAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; SALIVA;

EID: 33646841348     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.01.010     Document Type: Article

References (26)

1. Rutter J.M., Francis L.M.A., and Sansom B.F. Virulence of Bordetella bronchiseptica from pigs with or without atrophic rhinitis. J. Med. Microbiol. 15 (1982) 105-116
2. Brockmeier S.L., Register K.B., Magyar T., Lax A.J., Pullinger G.D., and Kunkle R.A. Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine. Infect. Immun. 70 (2002) 481-490
3. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., and Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10 (1992) 75-88
4. Holmgren J., Czerkinsky C., Lycke N., and Svennerholm A.M. Mucosal immunity: implications for vaccine development. Immunology 184 (1992) 157-179
5. Czerkinsky C., Anjuere F., McGhee J.R., George-Chandy A., Holmgren J., Kiney M.P., Fujiyashi K., Mesteeky J.F., Pierrefite-Carle V., Rask C., and Sun J.B. Mucosal immunity and tolerance; relevance to vaccine development. Immunol. Rev. 170 (1999) 197-222
6. Donovan M.D., Flynn G.L., and Amidon G.L. Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption. Pharm. Res. 7 (1990) 863-868
7. Schipper N.G., Verhoef J.C., and Merkus F.W. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm. Res. 8 (1991) 807-814
8. Sharkar M.A. Drug metabolism in nasal mucosa. Pharm. Res. 9 (1992) 1-9
9. Chandy T., and Sharma C.P. Chitosan - as a biomaterial biometer. Artif. Cells Artif. Org. 18 (1990) 1-24
10. Jabbal-Gill I., Fisher A.N., Rappuoli R., Davis S.S., and Illum L. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. Vaccine 20 (1998) 2039-2046
11. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A., and Davis S.S. Chitosan as a novel nasal delivery system for vaccines. Drug Deliv. Rev. 51 (2001) 81-96
12. Baudner B.C., Giuliani M.M., Verhoef J.C., Rappuoli R., Junginger H.E., and Giudice G.D. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. Vaccine 21 (2003) 3837-3844
13. Pereswetoff-Morath L. Microspheres as nasal drug delivery system. Adv. Drug Deliv. Rev. 29 (1998) 185-194
14. Varshosaz J., Sadrai H., and Alinagari R. Nasal delivery of insulin using chitosan microspheres. J. Microencapsul. 7 (2004) 761-774
15. Sankar C., Rani M., Srivastava A.K., and Mishra B. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie 56 (2001) 223-226
16. Jiang H.L., Park I.K., Shin N.R., Kang S.G., Yoo H.S., Kim S.I., Suh S.B., Akaike T., and Cho C.S. In vitro study of the immune stimulating activity of an atrophic rhinitis vaccine associated to chitosan microspheres. Eur. J. Pharm. Biopharm. 58 (2004) 471-476
17. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 11 (2005) S45-S53
18. Shin N.R., Choi I.S., Kim J.M., Hur W., and Yoo H.S. Effective methods for the production of immunoglobulin Y using immunogens of Bordetella bronchiseptica, Pasteurella multocida and Actinobacillus pleuropneumoniae. J. Vet. Sci. 3 (2002) 47-57
19. Park I.K., Jiang H.L., Yun C.H., Choi Y.J., Kim S.J., Akaike T., Kim S.I., and Cho C.S. Release of Newcastle disease virus from CMs in vitro and in vivo. Asian-Aust. J. Anim. Sci. 17 (2004) 543-547
20. Xu Y.M., and Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 250 (2003) 215-226
21. Berthold A., Cremer K., and Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control Rel. 39 (1996) 17-25
22. S. Miglani (Dhawan), Preparation and evaluation of controlled release oral dosage forms of glipizide and nifedipine. Ph.D. thesis, University Institute of Pharmaceutical Sciences, Punjab University, Chandigarh, India.
23. Lydyard P., and Grossi C. The lymphoid system. Immunology 5 (1998) 31-42
24. Wu H.Y., Nikolova E.B., Beagley K.W., and Russell M.W. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. Immunology 88 (1996) 493-500
25. Ellis J.A., Krakowka G.S., Dayton A.D., and Konoby C. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs. J. Am. Vet. Med. Assoc. 220 (2002) 43-48
26. de Jong M.F. Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine. Vet. Quart. 9 (1987) 123-133